Nordic walking to improve functional exercise capacity and daily physical activities in chronic obstructive pulmonary disease (COPD)

ISRCTN	ISRCTN31525632
DOI	https://doi.org/10.1186/ISRCTN31525632
Secondary identifying numbers	NA

Submission date: 11/03/2009
Registration date: 21/04/2009
Last edited: 21/04/2009

Recruitment status: No longer recruiting
Overall study status: Completed
Condition category: Respiratory

Prospectively registered

Protocol

Statistical analysis plan

Results

Individual participant data

Record updated in last year

Plain English summary of protocol

Not provided at time of registration

Contact information

Prof O C Burghuber
Scientific

Ludwig Boltzmann Institue for COPD
Sanatoriumstrasse 2
Vienna
1140
Austria

Study information

Study design	Randomised controlled trial
Primary study design	Interventional
Secondary study design	Randomised controlled trial
Study setting(s)	Hospital
Study type	Treatment
Scientific title	Nordic walking to improve functional exercise capacity and daily physical activities in chronic obstructive pulmonary disease (COPD): a randomised controlled trial
Study objectives	The aim of the present study was to determine whether and to what extent Nordic walking is feasible in increasing functional exercise capacity in patients with chronic obstructive pulmonary disease (COPD). Additionally, we aimed to determine short- and long-term effects of Nordic walking on daily physical activity level, exercise performance and mood status in patients with COPD.
Ethics approval(s)	Ethics Committee of Vienna (Ethikkommission der Stadt Wien), approved on 15/03/2006 (ref: EK 06-058-VK)
Health condition(s) or problem(s) studied	Chronic obstructive pulmonary disease (COPD)
Intervention	The participants were randomised to either the intervention or control group: Intervention group: 12 weeks outdoor Nordic walking exercise programme (1 hour per session, 3 times/week) Control group: no exercise intervention Patients randomised to the intervention group trained 3 times a week for 1 hour at recommended 75% of their initial maximum heart frequency obtained during initial maximum exercise test. In addition, the participants in the intervention group attended 1 hour/week educational sessions on pulmonary pathophysiology, management of breathlessness and exacerbations, clearance of pulmonary secretions, smoking cessation, medication and nutrition. The control group received 1 hour/month educational sessions.
Intervention type	Other
Primary outcome measure	Functional exercise capacity, assessed using the six minute walking test (6MWT). All primary and secondary outcome measures will be assessed at baseline and after 3, 6, and 9 month.
Secondary outcome measures	1. Daily physical activities, assessed using a tri-axial accelerometer (DynaPort® Activity Monitor; McRoberts BV, Netherlands) 2. Exercise-induced dyspnoea, assessed using the modified Borg Dyspnoea Scale 3. Mood status, assessed using the Hospital Anxiety and Depression Scale (HADS) All primary and secondary outcome measures will be assessed at baseline and after 3, 6, and 9 month.
Overall study start date	01/03/2006
Completion date	01/03/2007

Eligibility

Participant type(s)	Patient
Age group	Adult
Lower age limit	18 Years
Sex	Both
Target number of participants	60
Key inclusion criteria	1. Both males and females, age >18 years 2. Stable COPD (no infection or exacerbation for at least 12 weeks) 3. Absence of severe and/or unstable cardiac diseases (myocardial infarction within the last 6 month, cardiac arrhythmia Lown classification >IIIb, as shown by electrocardiogram during rest and maximal exercise test) 4. Absence of other pathologic conditions that could impair daily physical activities (cerebrovascular diseases, rheumatism, symptomatic osteoporosis and others)
Key exclusion criteria	Does not meet inclusion criteria
Date of first enrolment	01/03/2006
Date of final enrolment	01/03/2007

Locations

Countries of recruitment

Austria

Study participating centre

Ludwig Boltzmann Institue for COPD

Vienna
1140
Austria

Sponsor information

Ludwig Boltzmann Institute for COPD (Ludwid Boltzmann Institut für COPD) (Austria)
Research organisation

Sanatoriumstrasse 2
Vienna
1140
Austria

Website	http://www.lbg.ac.at
"ROR"	https://ror.org/01tf5aq62

Funders

Funder type

Research organisation

Ludwig Boltzmann Institute for COPD (Ludwid Boltzmann Institut für COPD) (Austria) - http://www.lbg.ac.at

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to share	No
IPD sharing plan summary	Not provided at time of registration
Publication and dissemination plan	Not provided at time of registration
IPD sharing plan